Company: MIRM
Filing Date: 2025-12-19
Form Type: 8-K
Source: 0001193125-25-325825
Chunk: 4

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-12-19
Form: 8-K
Item: Item 7.01
Chunk 4
---
Item 7.01      Regulation FD Disclosure.  

On December 19, 2025, the Company issued a press release announcing its entry into the Subscription Agreement, a copy of which is furnished as Exhibit 99.1 to this Form8-K.

As provided in General Instruction B.2 of Form8-K, the information in this Item 7.01, including Exhibit 99.1 hereto, shall not be deemed to be “filed” for purposes of, or otherwise subject to the liabilities under, Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.